Skip to main content
Equibles

Brevan Howard Capital Management LP

Position in EW — Edwards Lifesciences Corp

CIK 1512857 ST. HELIER, Y9
Back to EW Full portfolio

Position in EW

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,156,058
+$504,130 QoQ
Shares Held
34,889
+5.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#395
of 1,323 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $46,922,231 across 36 Medical Devices names. EW ranks #4 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 STE
STERIS plc
 20,654 $4,349,112
2 BIO
Bio-Rad Laboratories, Inc.
 13,718 $4,027,741
3 UFPT
Ufp Technologies Inc
 13,400 $3,552,742
4 EW
Edwards Lifesciences Corp
This page 		34,889 $3,156,058
5 TXG
10x Genomics, Inc.
 77,803 $2,982,967
6 BSX
Boston Scientific Corp
 68,883 $2,939,925
7 SYK
Stryker Corp
 9,013 $2,837,652
8 IRTC
iRhythm Holdings, Inc.
 23,847 $2,836,600

All Filings in EW

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,156,058 34,889
2026-03-31 $2,651,928 33,116
2025-12-31 $5,854,970 68,680
2025-09-30 $3,598,573 46,272
2025-06-30 $6,207,684 79,372
2025-03-31 $450,680 6,218
2024-12-31 $878,514 11,867
2024-09-30 $208,198 3,155
2024-06-30 $2,788,557 30,189
2024-03-31 $986,083 10,319
2023-12-31 $446,062 5,850